Current Surgical has secured $3.2 million in seed funding for its innovative cancer treatment technology

Sublime, an email tech startup based in Washington DC, has secured $9.8 million in funding.


Image Source:

Tech-guided needle uses micro-sized sensors to locate tumors


Destroy tumors using thermal ablation process


Aims to minimize damage to surrounding tissue


Funds will be used to reduce size of the technology and hire new team members


Image Source:

Long-term goal is to apply technology to all solid tumors and other conditions


Image Source:

Potential to revolutionize cancer treatment


Makes tumor removal easier for patients


Congrats to Current Surgical on this exciting milestone!


Stay tuned for more updates on this game-changing technology!